retatrutide nonalcoholic steatohepatitis trial fatty liver disease nash A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis Triple hormone receptor agonist retatrutide
Pay in 4 interest-free payments of $6.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30

























